AFJK

Aimei Health Technology Co., Ltd

There isn't enough reported data to score AFJK yet.

AFJK Fundamentals

MetricStatus
Unavailable
Stable
N/A
N/A

AFJK's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like AFJK.

AFJK PE Valuation

CHEAPFAIREXPENSIVE94x188x282x376x
CHEAPFAIREXPENSIVE94x188x282x376x
LevelPEPriceVs current
Cheap43x$2.15-83%
Fair50x$2.48-80%
Expensive242x$12.11-2.4%
Current248x$12.41โ€”

Historical ranges are pointers, not guarantees.

AFJK's PE is 248x, but its earnings don't support one, so it isn't a reliable read right now.

AFJK Forward outlook

There aren't enough analyst estimates for AFJK to show an outlook.

AFJK Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $12.41 on Nov 12.

There is not enough scenario data to assess AFJK's risk to reward.

AFJK Earnings Per Share

Q3 2024: $0.25Q4 2024: $0.28Q1 2025: $0.23Q2 2025: $0.23Q3 2025: $0.21Q4 2025: $0.17Q1 2026: $0.15Q2 2026: $0.05
Q3 2024: $0.25Q4 2024: $0.28Q1 2025: $0.23Q2 2025: $0.23Q3 2025: $0.21Q4 2025: $0.17Q1 2026: $0.15Q2 2026: $0.05
QuarterTTM EPSYoY
Q2 2026$0.05-78%
Q1 2026$0.15-35%
Q4 2025$0.17-39%
Q3 2025$0.21-16%

AFJK's earnings per share have fallen from their peak: $0.05 over the past year, against $0.28 in late 2024.

AFJK Quarterly Revenue

Q3 2023: --Q4 2023: $0Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: $0Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

AFJK Free Cash Flow

Q3 2023: --Q4 2023: $3,618Q1 2024: โˆ’$166,970Q2 2024: โˆ’$256,242Q3 2024: โˆ’$53,946Q4 2024: โˆ’$195,131Q1 2025: โˆ’$224,009Q2 2025: โˆ’$201,750Q3 2025: โˆ’$96,109Q4 2025: โˆ’$43,232Q1 2026: โˆ’$74,613Q2 2026: โˆ’$156,900
Q3 2023: --Q4 2023: $3,618Q1 2024: โˆ’$166,970Q2 2024: โˆ’$256,242Q3 2024: โˆ’$53,946Q4 2024: โˆ’$195,131Q1 2025: โˆ’$224,009Q2 2025: โˆ’$201,750Q3 2025: โˆ’$96,109Q4 2025: โˆ’$43,232Q1 2026: โˆ’$74,613Q2 2026: โˆ’$156,900
QuarterFree cash flowYoY
Q2 2026-$156.9K+$44.9K
Q1 2026-$74.6K+$149.4K
Q4 2025-$43.2K+$151.9K
Q3 2025-$96.1K-$42.2K
Q2 2025-$201.8K+$54.5K
Q1 2025-$224K-$57K
Q4 2024-$195.1K-5493%

AFJK's free cash flow was โˆ’$370,854 over the past year, against โˆ’$674,836 the year before. Free cash flow isn't a meaningful measure for financial services companies like AFJK.

AFJK Total Shares

Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 6MQ1 2025: 6MQ2 2025: 6MQ3 2025: 6MQ4 2025: 3MQ1 2026: 3MQ2 2026: 3M
Q4 2023: 9MQ1 2024: 9MQ2 2024: 9MQ3 2024: 9MQ4 2024: 6MQ1 2025: 6MQ2 2025: 6MQ3 2025: 6MQ4 2025: 3MQ1 2026: 3MQ2 2026: 3M
PeriodChange %Net change
Quarterly0%--
1 year-48%-3M shares

AFJK has 3M diluted shares, down 48% from a year ago.

AFJK Net Leverage

AFJK Weekly Momentum

MetricValueStatus
RSI35.7Neutral
Stochastic43.9Neutral

AFJK's weekly RSI is 36 (neutral) and its Stochastic is 44 (neutral).

AFJK PE vs Financial Services Sector

MetricAFJKSector medianRelative
PE248x13x1,806% above
PE %923656 pts above

AFJK is trading at 248x earnings, a 1806% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

AFJK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.21.8% above
20 week MA$12.94.1% below
50 week MA$29.658% below
100 week MA$20.339% below

AFJK has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 39% below its 100-week average.

AFJK Yearly ROI

YearStart priceEnd priceROI
2024$10.2$10.6+4.3%
2025$10.6$44.0+315%
2026 YTD$44.0$12.4-72%

AFJK has finished every year since 2024 higher, and it's down 72% so far in 2026.

Give your agent the market.

Get API key